Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 1
This study is for people with myeloma or lymphoma that has come back after standard treatment or has not responded to treatment.
Please note enough people with myeloma are taking part in the study. The team are no longer asking these people to join the study.
Recruitment start: 18 July 2014
Recruitment end: 28 September 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kwee Yong
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline
Last reviewed: 30 September 2018
CRUK internal database number: 12800
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
